Automated insulin early after type 1 diabetes diagnosis in kids
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 17 years old.
- You were diagnosed with type 1 diabetes 3 to 6 months ago.
- You have a positive antibody test for type 1 diabetes.
- You use multiple daily insulin injections or an insulin pump (with a feature that stops insulin if low blood sugar is predicted).
- You or your parents know how to count carbohydrates.
- You have a smartphone that can run the Dexcom G6 app and are willing to use the Dexcom G6 sensor and app throughout the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new experimental automated insulin delivery system (a type of 'artificial pancreas') to see if it is safe and works better than current systems. It may help people whose blood sugar is not well controlled with their current pump or system.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.